In her statement to the Inquiry, Dr Mayne noted that she performed liver function tests on patients at Belfast Haemophilia Centre as she was apprehensive about the long term effects of IV treatment. Read more about In her statement to the Inquiry, Dr Mayne noted that she performed liver function tests on patients at Belfast Haemophilia Centre as she was apprehensive about the long term effects of IV treatment.
In 1979 the vast bulk of treatment at the Belfast Haemophilia Centre was with commercial concentrates (Hemofil: 557,655 units, Kryobulin: 440,051). Read more about In 1979 the vast bulk of treatment at the Belfast Haemophilia Centre was with commercial concentrates (Hemofil: 557,655 units, Kryobulin: 440,051).
The Belfast Haemophilia annual returns for 1978 showed the use of cryoprecipitate (250,646), NHS concentrate (186,992), Hemofil (290,599) and Kryobulin (334,390). Read more about The Belfast Haemophilia annual returns for 1978 showed the use of cryoprecipitate (250,646), NHS concentrate (186,992), Hemofil (290,599) and Kryobulin (334,390).
The 1976 annual return recorded for the Belfast Haemophilia Centre the use of cryoprecipitate and commercial concentrates (Hemofil and Kryobulin). Some NHS concentrates were used. Read more about The 1976 annual return recorded for the Belfast Haemophilia Centre the use of cryoprecipitate and commercial concentrates (Hemofil and Kryobulin). Some NHS concentrates were used.
The 1977 annual return recorded that Belfast Haemophilia Centre used no NHS Factor VIII concentrate. Read more about The 1977 annual return recorded that Belfast Haemophilia Centre used no NHS Factor VIII concentrate.
Dr Mayne wrote to David Williams, explaining that in view of likely expansion of home treatment programme and increased needs for commercial Factor VIII, further order for Koate might be placed with Speywood. Read more about Dr Mayne wrote to David Williams, explaining that in view of likely expansion of home treatment programme and increased needs for commercial Factor VIII, further order for Koate might be placed with Speywood.
David Williams of Speywood noted that Dr Mayne was not prepared to change her policy concerning human factor VIII. Read more about David Williams of Speywood noted that Dr Mayne was not prepared to change her policy concerning human factor VIII.
Dr Mayne instituted a home treatment programme using commercial concentrate, whereby all home treatment patients were treated with Kryobulin, all hospital treatment was with Hemofil while children continued to be treated with cryoprecipitate. Read more about Dr Mayne instituted a home treatment programme using commercial concentrate, whereby all home treatment patients were treated with Kryobulin, all hospital treatment was with Hemofil while children continued to be treated with cryoprecipitate.
Patient discharge summary from Dr Mayne to Dr Wallace suggested the first use of Factor VIII concentrate in Belfast Haemophilia Centre. Read more about Patient discharge summary from Dr Mayne to Dr Wallace suggested the first use of Factor VIII concentrate in Belfast Haemophilia Centre.
Dr Mayne stated that the possible significance of asymptomatic hepatitis became apparent by 1978, when structural abnormalities of the liver were described in patients. Read more about Dr Mayne stated that the possible significance of asymptomatic hepatitis became apparent by 1978, when structural abnormalities of the liver were described in patients.